ONPATTRO® is a lipid-based siRNA nanoparticle designed to downregulate transthyretin in the liver for treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR) [14,15]. This evidence concerns the gene TTR and amyloidosis.